Aberrant expression of miR-218 and miR-204 in human mesial temporal lobe epilepsy and hippocampal sclerosis—Convergence on axonal guidance
Sanne S. Kaalund
Department of Cellular and Molecular Medicine, Wilhelm Johannsen Center for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
Research Laboratory for Stereology and Neuroscience, Bispebjerg Hospital, Copenhagen, Denmark
Search for more papers by this authorMorten T. Venø
Department of Molecular Biology and Genetics, Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark
Search for more papers by this authorMads Bak
Department of Cellular and Molecular Medicine, Wilhelm Johannsen Center for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorRikke S. Møller
Department of Cellular and Molecular Medicine, Wilhelm Johannsen Center for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
Danish Epilepsy Center, Dianalund, Denmark
Institute for Regional Health Services, University of Southern Denmark, Odense, Denmark
Search for more papers by this authorHenning Laursen
Laboratory of Neuropathology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
Search for more papers by this authorFlemming Madsen
Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
Search for more papers by this authorHelle Broholm
Laboratory of Neuropathology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
Search for more papers by this authorBjørn Quistorff
Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorPeter Uldall
Department of Pediatrics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
Search for more papers by this authorNiels Tommerup
Department of Cellular and Molecular Medicine, Wilhelm Johannsen Center for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorSakari Kauppinen
Department of Haematology, Aalborg University Hospital, Aalborg, Denmark
Search for more papers by this authorAnne Sabers
Department of Neurology, The Epilepsy Clinic, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Search for more papers by this authorKees Fluiter
Department of Neurogenetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Search for more papers by this authorLisbeth B. Møller
Department of Clinical Genetics, Applied Human Molecular Genetics, Kennedy Center, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark
Search for more papers by this authorAnne Y. Nossent
Laboratory for Molecular Cardiology, Department of Biomedical Sciences, The Danish National Research Foundation Centre for Cardiac Arrhythmia, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorAsli Silahtaroglu
Department of Cellular and Molecular Medicine, Wilhelm Johannsen Center for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorJørgen Kjems
Department of Molecular Biology and Genetics, Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark
Search for more papers by this authorEleonora Aronica
SEIN–Stichting Epilepsie Instellingen Nederland, Heemstede, The Netherlands
Department of (Neuro) Pathology, AZ Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
The senior authors who contributed equally to the manuscript.Search for more papers by this authorCorresponding Author
Zeynep Tümer
Department of Cellular and Molecular Medicine, Wilhelm Johannsen Center for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Genetics, Applied Human Molecular Genetics, Kennedy Center, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark
The senior authors who contributed equally to the manuscript.Address correspondence to Zeynep Tümer, Center for Applied Human Molecular Genetics, The Kennedy Center, Gl. Landevej 7, 2600 Glostrup, Denmark. E-mail: [email protected]Search for more papers by this authorSanne S. Kaalund
Department of Cellular and Molecular Medicine, Wilhelm Johannsen Center for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
Research Laboratory for Stereology and Neuroscience, Bispebjerg Hospital, Copenhagen, Denmark
Search for more papers by this authorMorten T. Venø
Department of Molecular Biology and Genetics, Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark
Search for more papers by this authorMads Bak
Department of Cellular and Molecular Medicine, Wilhelm Johannsen Center for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorRikke S. Møller
Department of Cellular and Molecular Medicine, Wilhelm Johannsen Center for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
Danish Epilepsy Center, Dianalund, Denmark
Institute for Regional Health Services, University of Southern Denmark, Odense, Denmark
Search for more papers by this authorHenning Laursen
Laboratory of Neuropathology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
Search for more papers by this authorFlemming Madsen
Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
Search for more papers by this authorHelle Broholm
Laboratory of Neuropathology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
Search for more papers by this authorBjørn Quistorff
Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorPeter Uldall
Department of Pediatrics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
Search for more papers by this authorNiels Tommerup
Department of Cellular and Molecular Medicine, Wilhelm Johannsen Center for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorSakari Kauppinen
Department of Haematology, Aalborg University Hospital, Aalborg, Denmark
Search for more papers by this authorAnne Sabers
Department of Neurology, The Epilepsy Clinic, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Search for more papers by this authorKees Fluiter
Department of Neurogenetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Search for more papers by this authorLisbeth B. Møller
Department of Clinical Genetics, Applied Human Molecular Genetics, Kennedy Center, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark
Search for more papers by this authorAnne Y. Nossent
Laboratory for Molecular Cardiology, Department of Biomedical Sciences, The Danish National Research Foundation Centre for Cardiac Arrhythmia, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorAsli Silahtaroglu
Department of Cellular and Molecular Medicine, Wilhelm Johannsen Center for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorJørgen Kjems
Department of Molecular Biology and Genetics, Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark
Search for more papers by this authorEleonora Aronica
SEIN–Stichting Epilepsie Instellingen Nederland, Heemstede, The Netherlands
Department of (Neuro) Pathology, AZ Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
The senior authors who contributed equally to the manuscript.Search for more papers by this authorCorresponding Author
Zeynep Tümer
Department of Cellular and Molecular Medicine, Wilhelm Johannsen Center for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Genetics, Applied Human Molecular Genetics, Kennedy Center, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark
The senior authors who contributed equally to the manuscript.Address correspondence to Zeynep Tümer, Center for Applied Human Molecular Genetics, The Kennedy Center, Gl. Landevej 7, 2600 Glostrup, Denmark. E-mail: [email protected]Search for more papers by this authorSummary
Objective
Mesial temporal lobe epilepsy (MTLE) is one of the most common types of the intractable epilepsies and is most often associated with hippocampal sclerosis (HS), which is characterized by pronounced loss of hippocampal pyramidal neurons. microRNAs (miRNAs) have been shown to be dysregulated in epilepsy and neurodegenerative diseases, and we hypothesized that miRNAs could be involved in the pathogenesis of MTLE and HS.
Methods
miRNA expression was quantified in hippocampal specimens from human patients using miRNA microarray and quantitative real-time polymerase chain reaction RT-PCR, and by RNA-seq on fetal brain specimens from domestic pigs. In situ hybridization was used to show the spatial distribution of miRNAs in the human hippocampus. The potential effect of miRNAs on targets genes was investigated using the dual luciferase reporter gene assay.
Results
miRNA expression profiling showed that 25 miRNAs were up-regulated and 5 were down-regulated in hippocampus biopsies of MTLE/HS patients compared to controls. We showed that miR-204 and miR-218 were significantly down-regulated in MTLE and HS, and both were expressed in neurons in all subfields of normal hippocampus. Moreover, miR-204 and miR-218 showed strong changes in expression during fetal development of the hippocampus in pigs, and we identified four target genes, involved in axonal guidance and synaptic plasticity, ROBO1, GRM1, SLC1A2, and GNAI2, as bona fide targets of miR-218. GRM1 was also shown to be a direct target of miR-204.
Significance
miR-204 and miR-218 are developmentally regulated in the hippocampus and may contribute to the molecular mechanisms underlying the pathogenesis of MTLE and HS.
Supporting Information
Filename | Description |
---|---|
epi12839-sup-0001-TableS1.docxWord document, 16.1 KB | Table S1. Luciferase primer sequences for PCR amplification of 3′UTRs and pre-miRNA. |
epi12839-sup-0002-TableS2.docxWord document, 15.3 KB | Table S2. Selected miRNA target genes. |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 2010; 51: 676–685.
- 2Engel J Jr, Wiebe S, French J, et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy. Epilepsia 2003; 44: 741–751.
- 3Aronica E, Gorter JA. Gene expression profile in temporal lobe epilepsy. Neuroscientist 2007; 13: 100–108.
- 4Blümcke I, Becker AJ, Klein C, et al. Temporal lobe epilepsy associated up-regulation of metabotropic glutamate receptors: correlated changes in mGluR1 mRNA and protein expression in experimental animals and human patients. J Neuropathol Exp Neurol 2000; 59: 1–10.
- 5Grigorenko E, Glazier S, Bell W, et al. Changes in glutamate receptor subunit composition in hippocampus and cortex in patients with refractory epilepsy. J Neurol Sci 1997; 153: 35–45.
- 6Lee TS, Mane S, Eid T, et al. Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes. Mol Med 2007; 13: 1–13.
- 7Mathern GW, Mendoza D, Lozada A, et al. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 1999; 52: 453–472.
- 8Ozbas-Gerçeker F, Redeker S, Boer K, et al. Serial analysis of gene expression in the hippocampus of patients with mesial temporal lobe epilepsy. Neuroscience 2006; 138: 457–474.
- 9Proper EA, Hoogland G, Kappen SM, et al. Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 2002; 125: 32–43.
- 10Hébert SS, Horré K, Nicolaï L, et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA 2008; 105: 6415–6420.
- 11Wang WX, Rajeev BW, Stromberg AJ, et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 2008; 28: 1213–1223.
- 12Johnson R, Zuccato C, Belyaev ND, et al. A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol Dis 2008; 29: 438–445.
- 13Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol 2007; 23: 175–205.
- 14Griffiths-Jones S, Saini HK, van Dongen S, et al. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36: D154–D158.
- 15Krichevsky AM, King KS, Donahue CP, et al. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 2003; 9: 1274–1281.
- 16Makeyev EV, Zhang J, Carrasco MA, et al. The microRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 2007; 27: 435–448.
- 17Giraldez AJ, Cinalli RM, Glasner ME, et al. MicroRNAs regulate brain morphogenesis in zebrafish. Science 2005; 308: 833–838.
- 18Schratt GM, Tuebing F, Nigh EA, et al. A brain-specific micro-RNA regulates dendritic spine development. Nature 2006; 439: 283–289.
- 19Aronica E, Fluiter K, Iyer A, et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 2010; 31: 1100–1107.
- 20Ashhab MU, Omran A, Kong H, et al. Expressions of tumor necrosis factor alpha and microRNA-155 in immature rat model of status epilepticus and children with mesial temporal lobe epilepsy. J Mol Neurosci 2013; 51: 950–958.
- 21Iyer A, Zurolo E, Prabowo A, et al. MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS ONE 2012; 7: e44789.
- 22Kan AA, van Erp S, Derijck AA, et al. Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response. Cell Mol Life Sci 2012; 69: 3127–3145.
- 23Peng J, Omran A, Ashhab MU, et al. Expression patterns of miR-124, miR-134, miR-132, and miR-21 in an immature rat model and children with mesial temporal lobe epilepsy. J Mol Neurosci 2013; 50: 291–297.
- 24McKiernan RC, Jimenez-Mateos EM, Bray I, et al. Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis. PLoS ONE 2012; 7: e35921.
- 25Lewis TL Jr, Courchet J, Polleux F. Cell biology in neuroscience: cellular and molecular mechanisms underlying axon formation, growth, and branching. J Cell Biol 2013; 202: 837–848.
- 26Magloczky Z. Sprouting in human temporal lobe epilepsy: excitatory pathways and axons of interneurons. Epilepsy Res 2010; 89: 52–59.
- 27Kim J, Inoue K, Ishii J, et al. A microRNA feedback circuit in midbrain dopamine neurons. Science 2007; 317: 1220–1224.
- 28Lippi G, Steinert JR, Marczylo EL, et al. Targeting of the Arpc3 actin nucleation factor by miR-29a/b regulates dendritic spine morphology. J Cell Biol 2011; 194: 889–904.
- 29Krichevsky AM, Sonntag KC, Isacson O, et al. Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 2006; 24: 857–864.
- 30Packer AN, Xing Y, Harper SQ, et al. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci 2008; 28: 14341–14346.
- 31Dickerson JW, Dobbing J. Prenatal and postnatal growth and development of the central nervous system of the pig. Proc R Soc Lond B Biol Sci 1967; 166: 384–395.
- 32Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979; 3: 79–83.
- 33Bak M, Silahtaroglu A, Møller M, et al. MicroRNA expression in the adult mouse central nervous system. RNA 2008; 14: 432–444.
- 34Saeed AI, Sharov V, White J, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003; 34: 374–378.
- 35Howe EA, Sinha R, Schlauch D, et al. RNA-Seq analysis in MeV. Bioinformatics 2011; 27: 3209–3210.
- 36Zhang Y, Schulz VP, Reed BD, et al. Functional genomic screen of human stem cell differentiation reveals pathways involved in neurodevelopment and neurodegeneration. Proc Natl Acad Sci USA 2013; 110: 12361–12366.
- 37Gorter JA, Iyer A, White I, et al. Hippocampal subregion-specific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy. Neurobiol Dis 2014; 62: 508–520.
- 38Fish JE, Wythe JD, Xiao T, et al. A Slit/miR-218/Robo regulatory loop is required during heart tube formation in zebrafish. Development 2011; 138: 1409–1419.
- 39Lie AA, Becker A, Behle K, et al. Up-regulation of the metabotropic glutamate receptor mGluR4 in hippocampal neurons with reduced seizure vulnerability. Ann Neurol 2000; 47: 26–35.
- 40Fang M, Liu GW, Pan YM, et al. Abnormal expression and spatiotemporal change of Slit2 in neurons and astrocytes in temporal lobe epileptic foci: a study of epileptic patients and experimental animals. Brain Res 2010; 1324: 14–23.
- 41Omran A, Peng J, Zhang C, et al. Interleukin-1beta and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy. Epilepsia 2012; 53: 1215–1224.
- 42Stumm RK, Rummel J, Junker V, et al. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 2002; 22: 5865–5878.
- 43Stumm RK, Zhou C, Ara T, et al. CXCR4 regulates interneuron migration in the developing neocortex. J Neurosci 2003; 23: 5123–5130.
- 44Marchionni I, Beaumont M, Maccaferri G. The chemokine CXCL12 and the HIV-1 envelope protein gp120 regulate spontaneous activity of Cajal-Retzius cells in opposite directions. J Physiol 2012; 590: 3185–3202.
- 45Wu JY, Feng L, Park HT, et al. The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 2001; 410: 948–952.
- 46Nicholls RE, Zhang XL, Bailey CP, et al. mGluR2 acts through inhibitory Galpha subunits to regulate transmission and long-term plasticity at hippocampal mossy fiber-CA3 synapses. Proc Natl Acad Sci USA 2006; 103: 6380–6385.
- 47Khan ZU, Gutierrez A. Distribution of C-terminal splice variant of G alpha i2 in rat and monkey brain. Neuroscience 2004; 127: 833–843.
- 48Notenboom RG, Hampson DR, Jansen GH, et al. Up-regulation of hippocampal metabotropic glutamate receptor 5 in temporal lobe epilepsy patients. Brain 2006; 129: 96–107.
- 49Young SR, Chuang SC, Zhao W, et al. Persistent receptor activity underlies group I mGluR-mediated cellular plasticity in CA3 neuron. J Neurosci 2013; 33: 2526–2540.
- 50Rothstein JD, Martin L, Levey AI, et al. Localization of neuronal and glial glutamate transporters. Neuron 1994; 13: 713–725.
- 51Reagan LP, Rosell DR, Wood GE, et al. Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci USA 2004; 101: 2179–2184.
- 52Tanaka K, Watase K, Manabe T, et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997; 276: 1699–1702.
- 53Guo H, Lai L, Butchbach ME, et al. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum Mol Genet 2003; 12: 2519–2532.
- 54Bjørnsen LP, Eid T, Holmseth S, et al. Changes in glial glutamate transporters in human epileptogenic hippocampus: inadequate explanation for high extracellular glutamate during seizures. Neurobiol Dis 2007; 25: 319–330.
- 55Gorter JA, Van Vliet EA, Proper EA, et al. Glutamate transporters alterations in the reorganizing dentate gyrus are associated with progressive seizure activity in chronic epileptic rats. J Comp Neurol 2002; 442: 365–377.
- 56DeSilva TM, Borenstein NS, Volpe JJ, et al. Expression of EAAT2 in neurons and protoplasmic astrocytes during human cortical development. J Comp Neurol 2012; 520: 3912–3932.